Follow the L'Air Liquide share price and the full insider trade history of the company, a listed issuer based in France. Shares are listed on FR FR, under the supervision of AMF. Operating in the Chemicals & Materials sector, L'Air Liquide has recorded 74 public disclosures. Market capitalisation: €114.6bn. The latest transaction was filed on 10 April 2026 (Cession). Among the most active insiders: FRANCOIS JACKOW. Every trade is accessible without an account.
Analysts rate L'Air Liquide Strong Buy (bullish), based on 20 analysts. Average price target: €184.07.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
25 of 74 declarations
Air Liquide is a leading French industrial group specialized in gases, technologies and services for industry and healthcare. Founded in Paris in 1902, the company was initially built around the production and industrial use of gases extracted from air, and over time expanded into a broad range of mission-critical solutions for the modern economy. Listed on Euronext Paris under ticker FR0000120073, it is one of the flagship companies of the French equity market. Air Liquide’s business model is centered on the production, packaging, transportation and distribution of industrial, medical and specialty gases, as well as the design and operation of related technologies and equipment. Its portfolio includes oxygen, nitrogen, hydrogen, argon, carbon dioxide and ultra-high-purity gases used across chemicals, metals, electronics, energy, food processing and laboratory applications. The group is also increasingly active in hydrogen solutions, carbon capture and the energy transition, which strengthens its positioning in decarbonization-related markets. In healthcare, Air Liquide provides homecare services, respiratory support, infusion therapies and certain hospital solutions. This gives the group a more resilient and less cyclical revenue base than heavy industry alone. As a result, Air Liquide is both a core industrial supplier and a healthcare services provider with strong technical expertise. Its offering is supported by long-term contracts, high operating complexity and significant capital intensity, all of which create meaningful barriers to entry. Air Liquide has a highly diversified international footprint, with operations in 59 countries and a broad customer base spanning many sectors of the economy. This global presence allows the group to serve multinational industrial customers as well as local businesses, especially in Europe, North America and Asia. The company serves around 4.3 million customers and patients and employs approximately 65,000 people worldwide. This extensive platform supports its ability to deliver steady growth based on innovation, customer proximity and operational excellence. Recent highlights include continued targeted investments in semiconductors, hydrogen and Asian growth markets, alongside stronger environmental commitments. In 2025, Air Liquide completed its ADVANCE strategic plan, which combined financial and non-financial objectives, reinforcing its profile as a long-term industrial leader focused on profitable growth, innovation and sustainable transition.